Maculopathy in patients with diabetes mellitus type 1 and type 2: Associations with risk factors

British Journal of Ophthalmology

Volumn 84, Issue 8, 2000, Pages 871-876

  Zander, Eckhard ^a   Herfurth, Sabine ^b   Bohl, Beate ^b   Heinke, Peter ^c   Kohnert, Klaus Dieter ^b   Kerner, Wolfgang ^a   Herrmann, Uwe ^a  

^a Clinical of Karlsburg   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c Institut fur Diabetes 'Gerhardt Katsch'   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BIOMICROSCOPY; CHOLESTEROL BLOOD LEVEL; COMPLICATION; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; ELECTROCARDIOGRAPHY; EXCRETION; EYE FUNDUS; EYE PHOTOGRAPHY; FLUORESCENCE ANGIOGRAPHY; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; RETINA MACULOPATHY; RISK FACTOR; STATISTICAL ANALYSIS; TEMPERATURE; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; VIBRATION; VISUAL ACUITY;

ADULT; AGED; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; LOGISTIC MODELS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 0033873206     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.84.8.871     Document Type: Article

References (39)

1. Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102:527-32.
2. Klein R, Klein BEK, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care 1992;15:1875-91.
3. Grunwald JE, Du Pont J, Riva CE. Retinal haemodynamics in patients with early diabetes mellitus. Br J Ophthalmol 1996;80:327-31.
4. Klein R, Moss SE, Klein BEK. New management concepts for timely diagnosis of diabetic retinopathy treatable by photocoagulation. Diabetes Care 1987;10:633-8.
5. Cunha-Vaz JG, Fairia de Abreu JR, Campos AJ, et al. Early breakdown of the blood-retina barrier in diabetes. Br J Ophthalmol 1975;59:649-56.
6. Cunha-Vaz JG, Travassos A. Breakdown of the blood-retina barriers and cystoid macular edema. Surv Ophthalmol 1984;28:485-92.
7. Ferris FL III, Davis MD, Aiello LM. Treatment of diabetic retinopathy. N Engl J Med 1999;341:667-78.
8. Ferris FL III, Patz A. Macular edema. A complication of diabetic retinopathy. Surv Ophthalmol 1984;28:452-61.
9. Moss SE, Klein R, Klein BEK. The incidence of vision loss in a diabetic population. Ophthalmology 1988;95:1340-8.
10. Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy IV. Diabetic macular edema. Ophthalmology 1984;91:1464-74.
11. Arend O, Wolf S, Jung F, et al. Retinal microcirculation in patients with diabetes mellitus: dynamic and morphological analysis of perifoveal capillary network. Br J Ophthalmol 1991;75:514-18.
12. Grunwald JE, Riva CE, Baine J, et al. Total retinal volumetric blood flow rate in diabetic patients with poor metabolic control. Invest Ophthalmol Vis Sci 1992;33:356-33.
13. Kohner EM, Hamilton AMP, Saunders SJ, et al. The retinal blood flow in diabetes. Diabetologia 1975;11:27-33.
14. Patel V, Rassam S, Newsom R, et al. Retinal blood flow in diabetic retinopathy. BMJ 1992;305:678-83.
15. Aiello LM, Rand LI, Briones JC, et al. Nonocular clinical risk factors in the progression of diabetic retinopathy. In: Little HL, Jack RL, Patz A, Forsham PH, eds. Diabetic retinopathy. New York: Thieme-Stratton, 1983:21-31.
16. British Multicenter Study Group. Photocoagulation for diabetic maculopathy: a randomized controlled clinical trial using the xenon arc. Diabetes 1983;32:1010-16.
17. Klein BEK, Moss SE, Klein R, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XIII. Relationship of serum cholesterol to retinopathy and hard exudates. Ophthalmology 1991;98:1261-5.
18. Myers FL, Davis MD, Magli YL. The natural course of diabetic retinopathy: a clinical study of 321 eyes followed one year or more. In: Goldberg MF, Fine SL, eds. Symposium on the treatment of diabetic retinopathy. Airlie House, Warrenton, Virginia, 29 September to 1 October 1968. Washington DC: US Government Printing Office (PHS Pub No 1890) 1969:81-5.
19. Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998;105:1801-5.
20. Seidlein I, Herfurth S. Klinisches Bild, Diagnostik, Klassifikation und Epidemiologie der diabetischen Retinopathie. Augenoptik (Berlin) 1990;107:7-9.
21. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 1. Arch Ophthalmol 1985;103:1769-806.
22. Helbig H, Bornfeld N. Diagnostik und Therapie der diabetischen Retinopathie. Diabetes und Stoffwechsel 1997;6:157-67.
23. Ziegler D, Laux G, Dannehl K, et al. Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis and standard tests of heart rate variation and blood pressure responses. Diabet Med 1992;9:166-75.
24. Gottschling HD, Jahr D, Diaz-Alonso JM, et al. Enzymimmunoassay zur Bestimmung von Albumin im Urin. Z med Labdiagn 1991;32:84-90.
25. Aiello LM, Rand LI, Briones JC, et al. Diabetic retinopathy in Joslin clinic patients with adult-onset diabetes. Ophthalmology 1981;88:619-23.
26. Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XIV Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994;112:1217-28.
27. Patz A, Schatz H, Berkow JW, et al. Macular edema - an overlooked complication of diabetic retinopathy. Trans Am Acad Ophthalmol Otolaryngol 1973;77:OP34-42.
28. Bresnick GH. Diabetic maculopathy: a critical review high-lighting diffuse macular edema. Ophthalmology 1983-90:1301-17.
29. Klein B, Klein R, Moss SE, et al. A cohort study of the relationship of diabetic retinopathy to blood pressure. Arch Ophthalmol 1995;113:601-6.
30. Maser RE, Steenkiste AR, Dorman JS, et al. Epidemiological correlates of diabetic neuropathy. Diabetes 1989;38:1456-61.
31. Ziegler D, Grieß FA, Spueler M, et al. The epidemiology of diabetic neuropathy. J Diabet Complications 1992;6:49-57.
32. Zander E, Heinke P, Herfurth S, et al. Relations between diabetic retinopathy and cardiovascular neuropathy. A cross-sectional study in IDDM and NIDDM patients. Exp Clin Endocrinol Diabetes 1997;105:19-26.
33. Fong DS, Warram JH, Aiello LM, et al. Cardiovascular autonomie neuropathy and proliferative diabetic retinopathy. Am J Ophthalmol 1995;120:317-21.
34. Furukawa H. Autonomic innervation of preretinal blood vessels of the rabbit. Invest Ophthalmol Vis Sci 1987;28:1752.
35. Stephanson E, Landers MB, Wolbarsht ML. Oxygenation and vasodilatation in relation to diabetic and other proliferative retinopathies. Ophthalmic Surg 1983;14:209-26.
36. Feke GT, Buzney SM, Ogasawara H, et al. Retinal circulatory abnormalities in type 1 diabetes. Invest Ophthalmol Vis Sci 1994;35:2968.
37. Zatz R, Brenner BM. Pathogenesis of diabetic microangiopathy: the hemodynamic view, Am J Med 1986;80:443.
38. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
39. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.